NanoEcho (OM:NANECH) - Stock Price, News & Analysis

NANECH Stock Overview

Develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes.

NANECH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Does not have a meaningful market cap (SEK45M)

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the Swedish market

NanoEcho AB (publ) Competitors

Scandinavian ChemoTech

OM:CMOTEC B

SEK 41.6m

Scandinavian Real Heart

OM:HEART

SEK 40.9m

Chordate Medical Holding

OM:CMH

SEK 40.6m

Fluicell

OM:FLUI

SEK 35.3m

Price History & Performance

Summary of all time highs, changes and price drops for NanoEcho
Historical stock prices
Current Share Price	SEK 0.26
52 Week High	SEK 0.80
52 Week Low	SEK 0.0059
Beta	0
11 Month Change	-22.09%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	47.03%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NANECH	SE Medical Equipment	SE Market
7D	1.0%	-3.6%	-0.2%
1Y	n/a	20.7%	28.4%

Return vs Industry: Insufficient data to determine how NANECH performed against the Swedish Medical Equipment industry.

Return vs Market: Insufficient data to determine how NANECH performed against the Swedish Market.

Price Volatility

Is NANECH's price volatile compared to industry and market?
NANECH volatility
NANECH Average Weekly Movement	43.1%
Medical Equipment Industry Average Movement	6.9%
Market Average Movement	5.3%
10% most volatile stocks in SE Market	11.5%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: NANECH's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: Insufficient data to determine NANECH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2013	n/a	Linda Persson	nanoecho.se

NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.

NanoEcho AB (publ) Fundamentals Summary

How do NanoEcho's earnings and revenue compare to its market cap?
NANECH fundamental statistics
Market cap	SEK 45.02m
Earnings (TTM)	SEK 0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is NANECH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NANECH income statement (TTM)
Revenue	SEK 0
Cost of Revenue	SEK 0
Gross Profit	SEK 0
Other Expenses	SEK 0
Earnings	SEK 0

Last Reported Earnings

n/a

Next Earnings Date

Oct 24, 2024

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NANECH perform over the long term?

See historical performance and comparison